OncoGenex Pharma (OGXI) Tops Q4 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/15/2026

1. NVDA
2. CRWV
3. SPY
4. BAC
5. BLK
6. CAT
7. AA
8. RKLB
9. FMC
10. MRSH

Go back to OncoGenex Pharma (OGXI) Tops Q4 EPS by 4c

OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2014

March 26, 2015 4:01 PM EDT

Conference call to be held on Thursday, March 26, 2015 at 4:30 p.m. Eastern Time

BOTHELL, Wash. and VANCOUVER, British Columbia, March 26, 2015 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today provided a summary of clinical developments and announced fourth quarter and year end 2014 financial results.

Clinical Developments and Anticipated Near-term Milestones

Custirsen

Collaboration: In December 2014, OncoGenex and Teva agreed to negotiate the termination of their collaboration and return custirsen rights to OncoGenex. Negotiations of the final termination agreement are ongoing. Two Phase 3 Trials: OncoGenex' custirsen... More